Skip to main content
. 2014 Jan 14;17(2):119–125. doi: 10.1038/pcan.2013.51

Figure 2.

Figure 2

Correlation of prostate cancer (PCa) risk and guanyl nucleotide-releasing protein for Ras 3 (RasGRP3) protein expression. PCa risk groups were stratified by low-risk groups (n=15), intermediate-risk groups (n=20) and high-risk groups (n=18), according to the National Comprehensive Cancer Network Guidelines. Immunostaining score of RasGRP3 protein expression was determined by immunohistochemistry.